These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15686213)

  • 21. Drug misuse.
    Ashworth AJ; Kidd BA
    Br J Gen Pract; 1998 Jul; 48(432):1435-6. PubMed ID: 9800413
    [No Abstract]   [Full Text] [Related]  

  • 22. A field-based dissemination component in a drug abuse research center.
    Sorensen JL; Clark WW
    NIDA Res Monogr; 1995; 155():186-97. PubMed ID: 8594456
    [No Abstract]   [Full Text] [Related]  

  • 23. Krever 2008.
    Schechter MT; O'Shaughnessy MV
    CMAJ; 1999 Apr; 160(8):1179-80. PubMed ID: 10234350
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV/AIDS prevention: problems and approaches to establishing needle exchange programs in rural areas.
    Reilly D
    Aust Health Rev; 1990; 13(2):127-32. PubMed ID: 10170677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV outreach and substance abuse treatment for Latino drug users: Implications for program planning.
    Lundgren LM; Delgado M
    Eval Program Plann; 2008 Feb; 31(1):61-3. PubMed ID: 18222141
    [No Abstract]   [Full Text] [Related]  

  • 26. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV/AIDS in India. The needle and the damage done.
    Cohen J
    Science; 2004 Apr; 304(5670):509-12. PubMed ID: 15105472
    [No Abstract]   [Full Text] [Related]  

  • 30. Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.
    Klein SJ; Birkhead GS; Candelas AR
    J Urban Health; 2000 Dec; 77(4):762-7. PubMed ID: 11194315
    [No Abstract]   [Full Text] [Related]  

  • 31. Harm reduction drug policies and practice: international developments and domestic initiatives. Overview of a symposium. March 22, 1995.
    Drucker E; Hantman JA
    Bull N Y Acad Med; 1995; 72(2):335-8. PubMed ID: 10101373
    [No Abstract]   [Full Text] [Related]  

  • 32. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient drug abuse treatment services, 1988: results of a national survey.
    Price RH; Burke AC; D'Aunno TA; Klingel DM; McCaughrin WC; Rafferty JA; Vaughn TE
    NIDA Res Monogr; 1991; 106():63-92. PubMed ID: 1656267
    [No Abstract]   [Full Text] [Related]  

  • 34. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Needle and syringe exchange programs in Amsterdam.
    Witteveen E; Schippers G
    Subst Use Misuse; 2006; 41(6-7):835-6. PubMed ID: 16809172
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of pharmacies in the care of drug users: what has changed in ten years. The case of a Swiss region.
    Samitca S; Huissoud T; Jeannin A; Dubois-Arber F
    Eur Addict Res; 2007; 13(1):50-6. PubMed ID: 17172779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of organization and management in substance abuse treatment: Review and roadmap.
    D'Aunno T
    J Subst Abuse Treat; 2006 Oct; 31(3):221-33. PubMed ID: 16996385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syringe exchange, injecting and intranasal drug use.
    Des Jarlais DC; Arasteh K; McKnight C; Ringer M; Friedman SR
    Addiction; 2010 Jan; 105(1):155-8. PubMed ID: 19891668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic strategies in schizophrenic drug abuse].
    Laqueille X
    Encephale; 2003 Sep; 29(Pt 2):S31-4. PubMed ID: 14710534
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.